Effects of a traditional Japanse herbal medicine yokukansan (YKS) for BPSD in DLB
Phase 3
- Conditions
- Dementia with Lewy bodies (DLB), Parkinson disease with dementia (PDD)
- Registration Number
- JPRN-UMIN000001511
- Lead Sponsor
- yokukansan-DLB research group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Malignancy 2.Severe life-thretning disease such as heart, liver, renal, blood diseases. 3.Other type of dementia i.e. Alzheimer disease, vascular dementia, FTD. 4.Neurodegenerative disease other than DLB or PD. 5.Other mental disorders such as depression, bipolardisorder,schizophrenia. 6.Hallucination due to alcohol abuse, drug abuse and / or other reasons 7. Use of neuroleptics (i.e. fluphenazine, haloperidol) within rescent 4 weeks. 8.Diagnosed as inadequate by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method europsychiatric Inventry at baseline and after 2 and 4 weeks of YKS treatment.
- Secondary Outcome Measures
Name Time Method MMSE, DAD, BEHAVE-AD, Zarit score, Fluctuation, biochemistry data at baseline and 4 weeks treatment